Difference between revisions of "Team:BioIQS-Barcelona"

 
(36 intermediate revisions by the same user not shown)
Line 11: Line 11:
  
 
     <!--script>
 
     <!--script>
 +
            if (typeof jQuery == 'undefined') {
 +
                console.log("jquery not loaded")
 +
            } else {
 +
                console.log("jquery is loaded")
 +
            }
 +
        </script-->
 +
 +
       
 +
    <script>
 
         var element = document.querySelector('[rel="stylesheet"]');
 
         var element = document.querySelector('[rel="stylesheet"]');
 
         var stylesheet = element.sheet || element.styleSheet;
 
         var stylesheet = element.sheet || element.styleSheet;
 
         console.log(stylesheet);
 
         console.log(stylesheet);
 
         stylesheet.disabled = true;
 
         stylesheet.disabled = true;
 +
    </script>
 +
 +
<!--script>
 +
        if (typeof jQuery == 'undefined') {
 +
            console.log("jquery not loaded after disabling")
 +
        } else {
 +
            console.log("jquery is loaded after diabling")
 +
        }
 
     </script-->
 
     </script-->
  
     <!--link rel="stylesheet" href="https://2018.igem.org/Template:BioIQS-Barcelona/css/goodload?action=raw&ctype=text/css"-->
+
     <link rel="stylesheet" href="https://2018.igem.org/Template:BioIQS-Barcelona/css/goodload?action=raw&ctype=text/css">
  
 
     <!-- Habilitar nomes al app per veure les funcions Jquery -->
 
     <!-- Habilitar nomes al app per veure les funcions Jquery -->
Line 42: Line 59:
 
     <link href="https://fonts.googleapis.com/css?family=Lato" rel="stylesheet">
 
     <link href="https://fonts.googleapis.com/css?family=Lato" rel="stylesheet">
 
     <link href="https://fonts.googleapis.com/css?family=Catamaran:100,200,300,400,500,600,700,800,900" rel="stylesheet">
 
     <link href="https://fonts.googleapis.com/css?family=Catamaran:100,200,300,400,500,600,700,800,900" rel="stylesheet">
     <link href="https://fonts.googleapis.com/css?family=Muli" rel="stylesheet">
+
     <link href="https://fonts.googleapis.com/css?family=Muli" rel="stylesheet">     
 +
    <!-- Importing fonts awesome, it doesnt work from allmin.css because of url('undefined'), needed to upload manually -->   
 +
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.5.0/css/all.css" integrity="sha384-B4dIYHKNBt8Bc12p+WXckhzcICo0wtJAoU8YZTY5qE0Id1GSseTk6S+L3BlXeVIU" crossorigin="anonymous">
  
  
Line 106: Line 125:
 
                     <div class="row justify-content-center">
 
                     <div class="row justify-content-center">
 
                         <div class="col-md-11 col-lg-7">
 
                         <div class="col-md-11 col-lg-7">
                             <p class="text-b"><b>Coeliac disease (CD)</b> is an autoimmune disorder that is closely related with HLA (Human Leukocyte Antigen), a type of cell-surface proteins that are responsible for the regulation of the inmune systems in humans.</p>
+
                             <p class="text-b"><b>Celiac disease (CD)</b> is an autoimmune disorder that is closely related with HLA (Human Leukocyte Antigen), a type of cell-surface proteins that are responsible for the regulation of the inmune systems in humans.</p>
 
                         </div>
 
                         </div>
 
                     </div>
 
                     </div>
Line 126: Line 145:
 
                 <div class="col-md-6 text-description">
 
                 <div class="col-md-6 text-description">
 
                     <p class="text-b fletxa-d">
 
                     <p class="text-b fletxa-d">
                         Within the HLA protein family there is a subset called HLA-DQ. There are several DQ isoforms that can bind to different gluten-derived epitopes and present them to T-cells. More specifically, 25% of the general population carry the HLA-DQ that can recognize gluten-derived epitopes, but only 1% of the population suffer from coeliac disease.
+
                         Within the HLA protein family there is a subset called HLA-DQ. There are several DQ isoforms that can bind to different gluten-derived epitopes and present them to T-cells. More specifically, 25% of the general population carry the <a href="https://2018.igem.org/Team:BioIQS-Barcelona/Celiac_disease">HLA-DQ haplotype</a> that recognizes gluten-derived epitopes, but only 1% of the population suffer from celiac disease.
 
                     </p>
 
                     </p>
  
 
                 </div>
 
                 </div>
 
                 <div class="col-md-6 end">
 
                 <div class="col-md-6 end">
                     <p class="apart yellow">As a consequence of T-cell activation, an inmune response is triggered, and it ends up causing damage to the enterocytes present in the small intestine.</p>
+
                     <p class="apart yellow">As a consequence of T-cell activation, an inmune response is triggered, causing damage to the enterocytes present in the small intestine.</p>
 
                     <!--                    <img src="images/hla-solo.png">-->
 
                     <!--                    <img src="images/hla-solo.png">-->
 
                 </div>
 
                 </div>
Line 149: Line 168:
 
                 </div>
 
                 </div>
 
                 <div class="col-md-8 end cnt block-desc-t">
 
                 <div class="col-md-8 end cnt block-desc-t">
                     <p class="apart yellow">The development of a personalized sensor to determine reactive epitopes could help to better understand the disease and would also allow the screening of those foods that could potentially trigger an immune response to the patient.</p>
+
                     <p class="apart yellow">The development of a personalized sensor to detect reactive epitopes could help to better understand the disease and would also allow the screening of those foods that could potentially trigger an immune response to the patient.</p>
 
                 </div>
 
                 </div>
  
Line 171: Line 190:
 
                     <div class="col-md-auto orange">
 
                     <div class="col-md-auto orange">
 
                         <p class="book">In our iGEM Project we will design a
 
                         <p class="book">In our iGEM Project we will design a
                             <b>personalized gluten sensor</b> through a synthetic biology approach. To do so, we decided to build a model based on the HLA expression of the patient which will be coupled to a sensor, allowing the detection of reactive gluten epitopes.</p>
+
                             <b>personalized gluten sensor</b> through a synthetic biology approach. To do so, we decided to build a <a href="https://2018.igem.org/Team:BioIQS-Barcelona/Model">model</a> based on the HLA expression of the patient which will be coupled to a sensor, allowing the detection of reactive gluten epitopes.</p>
 
                     </div>
 
                     </div>
 
                     <a class="js-scroll-trigger a-arrow" href="https://2018.igem.org/Team:BioIQS-Barcelona#t-objectives"><span class="arrow down"></span></a>
 
                     <a class="js-scroll-trigger a-arrow" href="https://2018.igem.org/Team:BioIQS-Barcelona#t-objectives"><span class="arrow down"></span></a>
Line 186: Line 205:
 
                         <div class="col-md-12">
 
                         <div class="col-md-12">
 
                             <p class="apart big">first</p>
 
                             <p class="apart big">first</p>
                             <p class="text-b">To obtain de HLA-DQ from scratch. That means, to extract the &alpha; and &beta; chains <b>from the genomic DNA of a celiac patient.</b></p>
+
                             <p class="text-b">To obtain de HLA-DQ from scratch. That means, to <a href="https://2018.igem.org/Team:BioIQS-Barcelona/Basic_Part" style="color: #032a5e; text-decoration: underline">extract</a> the &alpha; and &beta; chains <b>from the genomic DNA of a celiac patient.</b></p>
 
                         </div>
 
                         </div>
 
                          
 
                          
Line 196: Line 215:
 
                         <div class="col-md-12">
 
                         <div class="col-md-12">
 
                             <p class="apart big">second</p>
 
                             <p class="apart big">second</p>
                             <p class="text-b">To express the human HLA-DQ in a <b>bacterial or yeast cell host.</b></p>
+
                             <p class="text-b">To express the human HLA-DQ in a <b><a href="https://2018.igem.org/Team:BioIQS-Barcelona/Composite_Part" style="color: #032a5e; text-decoration: underline">bacterial</a> or yeast cell host.</b></p>
 
                         </div>
 
                         </div>
 
                        
 
                        
Line 207: Line 226:
 
                         <p class="apart big">third</p>
 
                         <p class="apart big">third</p>
 
                         <!--<img class="image" src="img/epitop.png" alt="Card image cap">-->
 
                         <!--<img class="image" src="img/epitop.png" alt="Card image cap">-->
                         <p class="text-b">To develop <b>non-dimensional mathematical and stochastic models</b> to understand and predict our sensor dynamics.</p>
+
                         <p class="text-b">To develop <b>non-dimensional mathematical and stochastic models</b> to understand and predict the <a href="https://2018.igem.org/Team:BioIQS-Barcelona/Model"  style="color: #032a5e; text-decoration: underline">sensor dynamics.</a></p>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
 
                 <div class="col-md-6 left">
 
                 <div class="col-md-6 left">
 
                     <p class="apart big">fourth</p>
 
                     <p class="apart big">fourth</p>
                     <p class="text-b">To provide information to the public so as to <b>clear up misunderstandings related to the celiac disease.</b></p>
+
                     <p class="text-b">To <a href="https://2018.igem.org/Team:BioIQS-Barcelona/Human_Practices" style="color: #032a5e; text-decoration: underline">provide information</a> to the public to <b>clear up common misunderstandings related to celiac disease.</b></p>
 
<!--                    <img class="img" src="img/win.png" alt="Card image cap">-->
 
<!--                    <img class="img" src="img/win.png" alt="Card image cap">-->
 
                 </div>
 
                 </div>

Latest revision as of 15:08, 10 December 2018

BIO IQS

We are the BioIQS iGEM team!

Explore our project!

Welcome to our page

A brief resume:

Our project is based on the design of a personalized gluten sensor by using the common tools of synthetic biology. There are already several sensors that are able to detect gluten in the food. However, there are milestones that still have not been overcome. We propose a robust model in which the HLA-DQ protein of a patient is expressed and used as a sensor to detect specific reactive gluten epitopes.

Celiac disease (CD) is an autoimmune disorder that is closely related with HLA (Human Leukocyte Antigen), a type of cell-surface proteins that are responsible for the regulation of the inmune systems in humans.

These molecules are responsible for the correct discrimination between what is self and foreign proteins, guaranteeing the correct immune response against foreign agents that can cause infections.

Within the HLA protein family there is a subset called HLA-DQ. There are several DQ isoforms that can bind to different gluten-derived epitopes and present them to T-cells. More specifically, 25% of the general population carry the HLA-DQ haplotype that recognizes gluten-derived epitopes, but only 1% of the population suffer from celiac disease.

As a consequence of T-cell activation, an inmune response is triggered, causing damage to the enterocytes present in the small intestine.

Understanding why the inflammatory response is triggered by a certain type of T cells upon epitope presentation by HLA-DQ molecules is essential to uncover the mechanism of CD. Since the first step for the immune response activation is the recognition and binding of the gluten epitope to the HLA-DQ receptor, we developed a sensor based on this principle.

The development of a personalized sensor to detect reactive epitopes could help to better understand the disease and would also allow the screening of those foods that could potentially trigger an immune response to the patient.

Objectives

Here there are:

In our iGEM Project we will design a personalized gluten sensor through a synthetic biology approach. To do so, we decided to build a model based on the HLA expression of the patient which will be coupled to a sensor, allowing the detection of reactive gluten epitopes.

first

To obtain de HLA-DQ from scratch. That means, to extract the α and β chains from the genomic DNA of a celiac patient.

second

To express the human HLA-DQ in a bacterial or yeast cell host.

third

To develop non-dimensional mathematical and stochastic models to understand and predict the sensor dynamics.

fourth

To provide information to the public to clear up common misunderstandings related to celiac disease.